6/15/2017

Haloperidol Decanoate Injection

Products Affected - Description

- Haloperidol Decanoate injection, Mylan Institutional, 50 mg/mL, 5 mL vial, 5 count, NDC 67457-0382-58

Reason for the Shortage

- Teva is not actively marketing haloperidol decanoate.
- West-Ward is not actively marketing haloperidol decanoate injection.
- Fresenius Kabi had haloperidol decanoate on shortage due to short-term manufacturing delays.
- Mylan discontinued haloperidol decanoate 5 mL multi-dose vials. The company did not provide a reason for the discontinuation.

Available Products

- Haldol decanoate injection, Janssen-Ortho-McNeil, 100 mg/mL, 1 mL ampule, 3 count, NDC 50458-0254-14
- Haldol decanoate injection, Janssen-Ortho-McNeil, 50 mg/mL, 1 mL ampule, 3 count, NDC 50458-0253-03
- Haloperidol Decanoate injection, Fresenius Kabi, 100 mg/mL, 1 mL vial, 1 count, NDC 63323-0471-01
- Haloperidol Decanoate injection, Fresenius Kabi, 100 mg/mL, 5 mL vial, 1 count, NDC 63323-0471-05
- Haloperidol Decanoate injection, Fresenius Kabi, 50 mg/mL, 1 mL vial, 1 count, NDC 63323-0469-01
- Haloperidol Decanoate injection, Fresenius Kabi, 50 mg/mL, 5 mL vial, 1 count, NDC 63323-0469-05
- Haloperidol Decanoate injection, Mylan Institutional, 100 mg/mL, 1 mL vial, 5 count, NDC 67457-0409-13
- Haloperidol Decanoate injection, Mylan Institutional, 100 mg/mL, 5 mL vial, 5 count, NDC 67457-0381-58
- Haloperidol Decanoate injection, Mylan Institutional, 50 mg/mL, 1 mL vial, 10 count, NDC 67457-0410-13
- Haloperidol Decanoate injection, Patriot Pharmaceuticals, 100 mg/mL, 1 mL ampule, 3 count, NDC 10147-0922-05
- Haloperidol Decanoate injection, Patriot Pharmaceuticals, 50 mg/mL, 1 mL ampule, 3 count, NDC 10147-0921-03

Estimated Resupply Dates

- All presentations are readily available.

Updated

Updated June 15, 2017 by Elyse MacDonald, PharmD, MS, BCPS. Created April 1, 2009 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.